1. Home
  2. STXS vs CFBK Comparison

STXS vs CFBK Comparison

Compare STXS & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • CFBK
  • Stock Information
  • Founded
  • STXS 1990
  • CFBK 1892
  • Country
  • STXS United States
  • CFBK United States
  • Employees
  • STXS N/A
  • CFBK N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CFBK Major Banks
  • Sector
  • STXS Health Care
  • CFBK Finance
  • Exchange
  • STXS Nasdaq
  • CFBK Nasdaq
  • Market Cap
  • STXS 151.3M
  • CFBK 154.9M
  • IPO Year
  • STXS 2004
  • CFBK 1998
  • Fundamental
  • Price
  • STXS $2.17
  • CFBK $23.97
  • Analyst Decision
  • STXS
  • CFBK Buy
  • Analyst Count
  • STXS 0
  • CFBK 1
  • Target Price
  • STXS N/A
  • CFBK $29.00
  • AVG Volume (30 Days)
  • STXS 270.0K
  • CFBK 34.5K
  • Earning Date
  • STXS 08-11-2025
  • CFBK 08-05-2025
  • Dividend Yield
  • STXS N/A
  • CFBK 1.19%
  • EPS Growth
  • STXS N/A
  • CFBK N/A
  • EPS
  • STXS N/A
  • CFBK 2.28
  • Revenue
  • STXS $27,510,000.00
  • CFBK $47,663,000.00
  • Revenue This Year
  • STXS $25.90
  • CFBK $35.39
  • Revenue Next Year
  • STXS $60.57
  • CFBK $10.11
  • P/E Ratio
  • STXS N/A
  • CFBK $10.35
  • Revenue Growth
  • STXS 1.50
  • CFBK 1.22
  • 52 Week Low
  • STXS $1.54
  • CFBK $17.60
  • 52 Week High
  • STXS $2.72
  • CFBK $31.17
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.27
  • CFBK 61.06
  • Support Level
  • STXS $2.00
  • CFBK $23.30
  • Resistance Level
  • STXS $2.36
  • CFBK $23.89
  • Average True Range (ATR)
  • STXS 0.11
  • CFBK 0.37
  • MACD
  • STXS -0.01
  • CFBK -0.01
  • Stochastic Oscillator
  • STXS 50.00
  • CFBK 87.65

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

Share on Social Networks: